Indeed, our data suggest that the NF1 intact microenvironment cells may be more sensitive to MEK inhibition than NF1−/− tumor cells at least in part due to how NF1 loss modulates Ras pathway activation and feedback regulation. The gene discussed is MAP2K7; the disease is neoplasm.